Polo-like-kinase 1 is a proviral host-factor for hepatitis B virus replication - Centre de recherche en cancérologie de Lyon (UMR INSERM 1052 ; CNRS 5286 ; Centre Léon Bérard) Accéder directement au contenu
Article Dans Une Revue Hepatology Année : 2017

Polo-like-kinase 1 is a proviral host-factor for hepatitis B virus replication

A.M. Diab
  • Fonction : Auteur
A. Foca
  • Fonction : Auteur
F. Fusil
  • Fonction : Auteur
T. Lahlali
  • Fonction : Auteur
P. Jalaguier
  • Fonction : Auteur
F. Amirache
  • Fonction : Auteur
L. N'Guyen
  • Fonction : Auteur
N. Isorce
  • Fonction : Auteur
Cosset François-Loïc
O.M. Andrisani
  • Fonction : Auteur

Résumé

Chronic Hepatitis B Virus (HBV) infection is a major risk factor for hepatocellular carcinoma (HCC) and current treatments for CHB and HCC are perfectible. Herein, we identified cellular Serine/Threonine Polo-like-kinase 1 (PLK1) as a positive effector of HBV replication. The aim of this study was to demonstrate the proviral role of PLK1 in HBV biosynthesis and validate PLK1 inhibition a potential antiviral strategy. To this end, we employed physiologically relevant HBV infection models of Primary Human Hepatocytes (PHH) and differentiated HepaRG cells, in conjunction with pharmacologic PLK1 inhibitors, siRNA-mediated knockdown, and overexpression of constitutively active PLK1 (PLK1CA ). In addition, humanized liver FRG mouse model was used to determine antiviral effect of PLK1 inhibitor BI-2536 on HBV infection in vivo. Lastly, in vitro PLK1 kinase assays and site-directed mutagenesis were employed to demonstrate HBV core protein (HBc) is a PLK1 substrate. We demonstrate HBV infection activated cellular PLK1 in PHH and dHepaRG cells. PLK1 inhibition by BI-2536 or siRNA-mediated knockdown suppressed, whereas overexpression of PLK1CA increased HBV DNA biosynthesis, supporting PLK1 effects on viral biosynthesis are specific, and PLK1 is a proviral cellular factor. Significantly, BI-2536 administration to HBV-infected humanized liver FRG mice strongly inhibited HBV infection, validating PLK1 as a novel antiviral target in vivo. The proviral action of PLK1 is associated with the biogenesis of the nucleocapsid, as BI-2536 leads to its decreased intracellular formation/accumulation. In this respect, our studies identified HBc as a PLK1 substrate in vitro, and mapped PLK1 phosphorylation sites on this protein. PLK1 is a proviral host factor that could be envisaged as a target for combined antiviral and anti-tumoral strategies against HBV infection and HBV mediated carcinogenesis. This article is protected by copyright. All rights reserved

Dates et versions

hal-01795712 , version 1 (18-05-2018)

Identifiants

Citer

A.M. Diab, A. Foca, F. Fusil, T. Lahlali, P. Jalaguier, et al.. Polo-like-kinase 1 is a proviral host-factor for hepatitis B virus replication. Hepatology, 2017, 1527-3350 (Electronic), ⟨10.1002/hep.29236⟩. ⟨hal-01795712⟩
25 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More